Charles Schwab
BMY icon

Charles Schwab’s Bristol-Myers Squibb BMY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.28B Buy
70,802,680
+10,195,775
+17% +$472M 0.57% 35
2025
Q1
$3.7B Buy
60,606,905
+306,430
+0.5% +$18.7M 0.69% 34
2024
Q4
$3.41B Sell
60,300,475
-729,928
-1% -$41.3M 0.63% 33
2024
Q3
$3.16B Buy
61,030,403
+1,968,729
+3% +$102M 0.6% 34
2024
Q2
$2.45B Buy
59,061,674
+5,345,708
+10% +$222M 0.47% 43
2024
Q1
$2.91B Buy
53,715,966
+42,354,249
+373% +$2.3B 0.67% 28
2023
Q4
$583M Buy
11,361,717
+134,815
+1% +$6.92M 0.15% 119
2023
Q3
$652M Buy
11,226,902
+1,128
+0% +$65.5K 0.19% 95
2023
Q2
$718M Sell
11,225,774
-127,692
-1% -$8.17M 0.21% 83
2023
Q1
$787M Buy
11,353,466
+146,367
+1% +$10.1M 0.24% 78
2022
Q4
$806M Buy
11,207,099
+70,887
+0.6% +$5.1M 0.26% 73
2022
Q3
$792M Buy
11,136,212
+311,466
+3% +$22.1M 0.28% 62
2022
Q2
$834M Sell
10,824,746
-180,727
-2% -$13.9M 0.29% 65
2022
Q1
$804M Buy
11,005,473
+197,000
+2% +$14.4M 0.24% 78
2021
Q4
$674M Buy
10,808,473
+129,007
+1% +$8.04M 0.2% 93
2021
Q3
$632M Buy
10,679,466
+326,265
+3% +$19.3M 0.21% 88
2021
Q2
$692M Buy
10,353,201
+204,683
+2% +$13.7M 0.23% 78
2021
Q1
$641M Sell
10,148,518
-372,144
-4% -$23.5M 0.23% 81
2020
Q4
$653M Buy
10,520,662
+19,751
+0.2% +$1.23M 0.26% 74
2020
Q3
$633M Sell
10,500,911
-661,878
-6% -$39.9M 0.29% 69
2020
Q2
$656M Sell
11,162,789
-8,458,990
-43% -$497M 0.32% 58
2020
Q1
$1.09B Sell
19,621,779
-40,694
-0.2% -$2.27M 0.64% 27
2019
Q4
$1.26B Buy
19,662,473
+5,861,939
+42% +$376M 0.68% 22
2019
Q3
$700M Buy
13,800,534
+371,981
+3% +$18.9M 0.41% 40
2019
Q2
$609M Buy
13,428,553
+593,222
+5% +$26.9M 0.37% 47
2019
Q1
$612M Buy
12,835,331
+6,027,123
+89% +$288M 0.39% 39
2018
Q4
$354M Buy
6,808,208
+273,010
+4% +$14.2M 0.27% 68
2018
Q3
$406M Buy
6,535,198
+251,993
+4% +$15.6M 0.27% 66
2018
Q2
$348M Buy
6,283,205
+172,417
+3% +$9.54M 0.25% 70
2018
Q1
$387M Buy
6,110,788
+229,151
+4% +$14.5M 0.3% 56
2017
Q4
$360M Buy
5,881,637
+263,197
+5% +$16.1M 0.29% 56
2017
Q3
$358M Buy
5,618,440
+216,099
+4% +$13.8M 0.31% 50
2017
Q2
$301M Buy
5,402,341
+270,982
+5% +$15.1M 0.28% 55
2017
Q1
$279M Buy
5,131,359
+227,978
+5% +$12.4M 0.28% 57
2016
Q4
$287M Buy
4,903,381
+193,619
+4% +$11.3M 0.31% 52
2016
Q3
$254M Buy
4,709,762
+90,897
+2% +$4.9M 0.3% 52
2016
Q2
$340M Buy
4,618,865
+131,618
+3% +$9.68M 0.42% 41
2016
Q1
$287M Buy
4,487,247
+107,148
+2% +$6.84M 0.38% 46
2015
Q4
$301M Buy
4,380,099
+149,556
+4% +$10.3M 0.41% 45
2015
Q3
$250M Sell
4,230,543
-36,528
-0.9% -$2.16M 0.37% 49
2015
Q2
$284M Buy
4,267,071
+66,201
+2% +$4.41M 0.39% 50
2015
Q1
$271M Buy
4,200,870
+187,738
+5% +$12.1M 0.38% 50
2014
Q4
$237M Buy
4,013,132
+88,722
+2% +$5.24M 0.36% 51
2014
Q3
$201M Sell
3,924,410
-307,636
-7% -$15.7M 0.33% 55
2014
Q2
$205M Buy
4,232,046
+245,281
+6% +$11.9M 0.35% 53
2014
Q1
$207M Sell
3,986,765
-638,012
-14% -$33.1M 0.37% 49
2013
Q4
$246M Buy
4,624,777
+247,182
+6% +$13.1M 0.47% 40
2013
Q3
$207M Buy
4,377,595
+365,855
+9% +$17.3M 0.42% 41
2013
Q2
$180M Buy
+4,011,740
New +$180M 0.4% 40